Antibiotics and Hydroxychloroquine in Crohn's

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

April 18, 2019

Study Completion Date

September 30, 2019

Conditions

Crohn's Disease

Interventions

DRUG

Ciprofloxacin

experimental

DRUG

Doxycycline

experimental

DRUG

Hydroxychloroquine

oral

DRUG

Budesonide

active comparator

Trial Locations (1)

Royal Liverpool and Broadgreen Unversity Hospitals Trust, Liverpool

All Listed Sponsors

collaborator

National Association for Colitis and Crohn's Disease

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Royal Liverpool University Hospital

OTHER_GOV

NCT01783106 - Antibiotics and Hydroxychloroquine in Crohn's | Biotech Hunter | Biotech Hunter